The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Immunoglobulin (pH4) for Intravenous Injection Market Research Report 2024
Synopsis
The immunoglobulin combination was separated and extracted from normal human plasma by the low-temperature ethanol method, and refined through further processing and virus inactivation steps. This product is a complete, unmodified natural lgG antibody with a purity of up to 98%. It contains no preservatives and antibiotics and is intended for intravenous infusion. Compared with intramuscular gamma globulin, it has a faster effect and a significant effect. advantage.
The global Human Immunoglobulin (pH4) for Intravenous Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Immunoglobulin (pH4) for Intravenous Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Immunoglobulin (pH4) for Intravenous Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Human Immunoglobulin (pH4) for Intravenous Injection include Boya-Bio, Beijing Tiantan Biological Products, Hualan Bio, Guangdong Shuagnlin Bio-pharmacy, Weiguang Biological, Sinopharm, Shanghai RAAS, CTBB and Nanyue Biopharming, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Immunoglobulin (pH4) for Intravenous Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Immunoglobulin (pH4) for Intravenous Injection.
Report Scope
The Human Immunoglobulin (pH4) for Intravenous Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Immunoglobulin (pH4) for Intravenous Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Immunoglobulin (pH4) for Intravenous Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boya-Bio
Beijing Tiantan Biological Products
Hualan Bio
Guangdong Shuagnlin Bio-pharmacy
Weiguang Biological
Sinopharm
Shanghai RAAS
CTBB
Nanyue Biopharming
Segment by Type
1g/20ml
1.25g/25ml
2.5g/50ml
5g/100ml
10g/200ml
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Immunoglobulin (pH4) for Intravenous Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Immunoglobulin (pH4) for Intravenous Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The immunoglobulin combination was separated and extracted from normal human plasma by the low-temperature ethanol method, and refined through further processing and virus inactivation steps. This product is a complete, unmodified natural lgG antibody with a purity of up to 98%. It contains no preservatives and antibiotics and is intended for intravenous infusion. Compared with intramuscular gamma globulin, it has a faster effect and a significant effect. advantage.
The global Human Immunoglobulin (pH4) for Intravenous Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Immunoglobulin (pH4) for Intravenous Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Immunoglobulin (pH4) for Intravenous Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Human Immunoglobulin (pH4) for Intravenous Injection include Boya-Bio, Beijing Tiantan Biological Products, Hualan Bio, Guangdong Shuagnlin Bio-pharmacy, Weiguang Biological, Sinopharm, Shanghai RAAS, CTBB and Nanyue Biopharming, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Immunoglobulin (pH4) for Intravenous Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Immunoglobulin (pH4) for Intravenous Injection.
Report Scope
The Human Immunoglobulin (pH4) for Intravenous Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Immunoglobulin (pH4) for Intravenous Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Immunoglobulin (pH4) for Intravenous Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boya-Bio
Beijing Tiantan Biological Products
Hualan Bio
Guangdong Shuagnlin Bio-pharmacy
Weiguang Biological
Sinopharm
Shanghai RAAS
CTBB
Nanyue Biopharming
Segment by Type
1g/20ml
1.25g/25ml
2.5g/50ml
5g/100ml
10g/200ml
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Immunoglobulin (pH4) for Intravenous Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Immunoglobulin (pH4) for Intravenous Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Immunoglobulin (pH4) for Intravenous Injection Market Overview
1.1 Product Overview and Scope of Human Immunoglobulin (pH4) for Intravenous Injection
1.2 Human Immunoglobulin (pH4) for Intravenous Injection Segment by Type
1.2.1 Global Human Immunoglobulin (pH4) for Intravenous Injection Market Value Comparison by Type (2024-2030)
1.2.2 1g/20ml
1.2.3 1.25g/25ml
1.2.4 2.5g/50ml
1.2.5 5g/100ml
1.2.6 10g/200ml
1.3 Human Immunoglobulin (pH4) for Intravenous Injection Segment by Application
1.3.1 Global Human Immunoglobulin (pH4) for Intravenous Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Human Immunoglobulin (pH4) for Intravenous Injection Market Size Estimates and Forecasts
1.4.1 Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue 2019-2030
1.4.2 Global Human Immunoglobulin (pH4) for Intravenous Injection Sales 2019-2030
1.4.3 Global Human Immunoglobulin (pH4) for Intravenous Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Immunoglobulin (pH4) for Intravenous Injection Market Competition by Manufacturers
2.1 Global Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Immunoglobulin (pH4) for Intravenous Injection Average Price by Manufacturers (2019-2024)
2.4 Global Human Immunoglobulin (pH4) for Intravenous Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Immunoglobulin (pH4) for Intravenous Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Immunoglobulin (pH4) for Intravenous Injection, Product Type & Application
2.7 Human Immunoglobulin (pH4) for Intravenous Injection Market Competitive Situation and Trends
2.7.1 Human Immunoglobulin (pH4) for Intravenous Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Immunoglobulin (pH4) for Intravenous Injection Players Market Share by Revenue
2.7.3 Global Human Immunoglobulin (pH4) for Intravenous Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Immunoglobulin (pH4) for Intravenous Injection Retrospective Market Scenario by Region
3.1 Global Human Immunoglobulin (pH4) for Intravenous Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Immunoglobulin (pH4) for Intravenous Injection Global Human Immunoglobulin (pH4) for Intravenous Injection Sales by Region: 2019-2030
3.2.1 Global Human Immunoglobulin (pH4) for Intravenous Injection Sales by Region: 2019-2024
3.2.2 Global Human Immunoglobulin (pH4) for Intravenous Injection Sales by Region: 2025-2030
3.3 Global Human Immunoglobulin (pH4) for Intravenous Injection Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Region: 2019-2030
3.3.1 Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Region: 2019-2024
3.3.2 Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Region: 2025-2030
3.4 North America Human Immunoglobulin (pH4) for Intravenous Injection Market Facts & Figures by Country
3.4.1 North America Human Immunoglobulin (pH4) for Intravenous Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Immunoglobulin (pH4) for Intravenous Injection Sales by Country (2019-2030)
3.4.3 North America Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Immunoglobulin (pH4) for Intravenous Injection Market Facts & Figures by Country
3.5.1 Europe Human Immunoglobulin (pH4) for Intravenous Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Immunoglobulin (pH4) for Intravenous Injection Sales by Country (2019-2030)
3.5.3 Europe Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Immunoglobulin (pH4) for Intravenous Injection Market Facts & Figures by Country
3.7.1 Latin America Human Immunoglobulin (pH4) for Intravenous Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Immunoglobulin (pH4) for Intravenous Injection Sales by Country (2019-2030)
3.7.3 Latin America Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Immunoglobulin (pH4) for Intravenous Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Immunoglobulin (pH4) for Intravenous Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Immunoglobulin (pH4) for Intravenous Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Immunoglobulin (pH4) for Intravenous Injection Sales by Type (2019-2030)
4.1.1 Global Human Immunoglobulin (pH4) for Intravenous Injection Sales by Type (2019-2024)
4.1.2 Global Human Immunoglobulin (pH4) for Intravenous Injection Sales by Type (2025-2030)
4.1.3 Global Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Type (2019-2030)
4.2 Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Type (2019-2030)
4.2.1 Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Type (2019-2024)
4.2.2 Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Type (2025-2030)
4.2.3 Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue Market Share by Type (2019-2030)
4.3 Global Human Immunoglobulin (pH4) for Intravenous Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Immunoglobulin (pH4) for Intravenous Injection Sales by Application (2019-2030)
5.1.1 Global Human Immunoglobulin (pH4) for Intravenous Injection Sales by Application (2019-2024)
5.1.2 Global Human Immunoglobulin (pH4) for Intravenous Injection Sales by Application (2025-2030)
5.1.3 Global Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Application (2019-2030)
5.2 Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Application (2019-2030)
5.2.1 Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Application (2019-2024)
5.2.2 Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Application (2025-2030)
5.2.3 Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue Market Share by Application (2019-2030)
5.3 Global Human Immunoglobulin (pH4) for Intravenous Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boya-Bio
6.1.1 Boya-Bio Corporation Information
6.1.2 Boya-Bio Description and Business Overview
6.1.3 Boya-Bio Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boya-Bio Human Immunoglobulin (pH4) for Intravenous Injection Product Portfolio
6.1.5 Boya-Bio Recent Developments/Updates
6.2 Beijing Tiantan Biological Products
6.2.1 Beijing Tiantan Biological Products Corporation Information
6.2.2 Beijing Tiantan Biological Products Description and Business Overview
6.2.3 Beijing Tiantan Biological Products Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Beijing Tiantan Biological Products Human Immunoglobulin (pH4) for Intravenous Injection Product Portfolio
6.2.5 Beijing Tiantan Biological Products Recent Developments/Updates
6.3 Hualan Bio
6.3.1 Hualan Bio Corporation Information
6.3.2 Hualan Bio Description and Business Overview
6.3.3 Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection Product Portfolio
6.3.5 Hualan Bio Recent Developments/Updates
6.4 Guangdong Shuagnlin Bio-pharmacy
6.4.1 Guangdong Shuagnlin Bio-pharmacy Corporation Information
6.4.2 Guangdong Shuagnlin Bio-pharmacy Description and Business Overview
6.4.3 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin (pH4) for Intravenous Injection Product Portfolio
6.4.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
6.5 Weiguang Biological
6.5.1 Weiguang Biological Corporation Information
6.5.2 Weiguang Biological Description and Business Overview
6.5.3 Weiguang Biological Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Weiguang Biological Human Immunoglobulin (pH4) for Intravenous Injection Product Portfolio
6.5.5 Weiguang Biological Recent Developments/Updates
6.6 Sinopharm
6.6.1 Sinopharm Corporation Information
6.6.2 Sinopharm Description and Business Overview
6.6.3 Sinopharm Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sinopharm Human Immunoglobulin (pH4) for Intravenous Injection Product Portfolio
6.6.5 Sinopharm Recent Developments/Updates
6.7 Shanghai RAAS
6.6.1 Shanghai RAAS Corporation Information
6.6.2 Shanghai RAAS Description and Business Overview
6.6.3 Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection Product Portfolio
6.7.5 Shanghai RAAS Recent Developments/Updates
6.8 CTBB
6.8.1 CTBB Corporation Information
6.8.2 CTBB Description and Business Overview
6.8.3 CTBB Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CTBB Human Immunoglobulin (pH4) for Intravenous Injection Product Portfolio
6.8.5 CTBB Recent Developments/Updates
6.9 Nanyue Biopharming
6.9.1 Nanyue Biopharming Corporation Information
6.9.2 Nanyue Biopharming Description and Business Overview
6.9.3 Nanyue Biopharming Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nanyue Biopharming Human Immunoglobulin (pH4) for Intravenous Injection Product Portfolio
6.9.5 Nanyue Biopharming Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Immunoglobulin (pH4) for Intravenous Injection Industry Chain Analysis
7.2 Human Immunoglobulin (pH4) for Intravenous Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Immunoglobulin (pH4) for Intravenous Injection Production Mode & Process
7.4 Human Immunoglobulin (pH4) for Intravenous Injection Sales and Marketing
7.4.1 Human Immunoglobulin (pH4) for Intravenous Injection Sales Channels
7.4.2 Human Immunoglobulin (pH4) for Intravenous Injection Distributors
7.5 Human Immunoglobulin (pH4) for Intravenous Injection Customers
8 Human Immunoglobulin (pH4) for Intravenous Injection Market Dynamics
8.1 Human Immunoglobulin (pH4) for Intravenous Injection Industry Trends
8.2 Human Immunoglobulin (pH4) for Intravenous Injection Market Drivers
8.3 Human Immunoglobulin (pH4) for Intravenous Injection Market Challenges
8.4 Human Immunoglobulin (pH4) for Intravenous Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Human Immunoglobulin (pH4) for Intravenous Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Human Immunoglobulin (pH4) for Intravenous Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Human Immunoglobulin (pH4) for Intravenous Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Human Immunoglobulin (pH4) for Intravenous Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Human Immunoglobulin (pH4) for Intravenous Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Immunoglobulin (pH4) for Intravenous Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Immunoglobulin (pH4) for Intravenous Injection, Product Type & Application
Table 12. Global Key Manufacturers of Human Immunoglobulin (pH4) for Intravenous Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Immunoglobulin (pH4) for Intravenous Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunoglobulin (pH4) for Intravenous Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Immunoglobulin (pH4) for Intravenous Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Region (2019-2024)
Table 19. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Region (2025-2030)
Table 21. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Human Immunoglobulin (pH4) for Intravenous Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Human Immunoglobulin (pH4) for Intravenous Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Human Immunoglobulin (pH4) for Intravenous Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Human Immunoglobulin (pH4) for Intravenous Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Human Immunoglobulin (pH4) for Intravenous Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Human Immunoglobulin (pH4) for Intravenous Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Human Immunoglobulin (pH4) for Intravenous Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Human Immunoglobulin (pH4) for Intravenous Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Type (2019-2024)
Table 53. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Type (2025-2030)
Table 54. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Human Immunoglobulin (pH4) for Intravenous Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Human Immunoglobulin (pH4) for Intravenous Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Application (2019-2024)
Table 63. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Application (2025-2030)
Table 64. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Human Immunoglobulin (pH4) for Intravenous Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Human Immunoglobulin (pH4) for Intravenous Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Boya-Bio Corporation Information
Table 71. Boya-Bio Description and Business Overview
Table 72. Boya-Bio Human Immunoglobulin (pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Boya-Bio Human Immunoglobulin (pH4) for Intravenous Injection Product
Table 74. Boya-Bio Recent Developments/Updates
Table 75. Beijing Tiantan Biological Products Corporation Information
Table 76. Beijing Tiantan Biological Products Description and Business Overview
Table 77. Beijing Tiantan Biological Products Human Immunoglobulin (pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Beijing Tiantan Biological Products Human Immunoglobulin (pH4) for Intravenous Injection Product
Table 79. Beijing Tiantan Biological Products Recent Developments/Updates
Table 80. Hualan Bio Corporation Information
Table 81. Hualan Bio Description and Business Overview
Table 82. Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection Product
Table 84. Hualan Bio Recent Developments/Updates
Table 85. Guangdong Shuagnlin Bio-pharmacy Corporation Information
Table 86. Guangdong Shuagnlin Bio-pharmacy Description and Business Overview
Table 87. Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin (pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin (pH4) for Intravenous Injection Product
Table 89. Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
Table 90. Weiguang Biological Corporation Information
Table 91. Weiguang Biological Description and Business Overview
Table 92. Weiguang Biological Human Immunoglobulin (pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Weiguang Biological Human Immunoglobulin (pH4) for Intravenous Injection Product
Table 94. Weiguang Biological Recent Developments/Updates
Table 95. Sinopharm Corporation Information
Table 96. Sinopharm Description and Business Overview
Table 97. Sinopharm Human Immunoglobulin (pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Sinopharm Human Immunoglobulin (pH4) for Intravenous Injection Product
Table 99. Sinopharm Recent Developments/Updates
Table 100. Shanghai RAAS Corporation Information
Table 101. Shanghai RAAS Description and Business Overview
Table 102. Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection Product
Table 104. Shanghai RAAS Recent Developments/Updates
Table 105. CTBB Corporation Information
Table 106. CTBB Description and Business Overview
Table 107. CTBB Human Immunoglobulin (pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. CTBB Human Immunoglobulin (pH4) for Intravenous Injection Product
Table 109. CTBB Recent Developments/Updates
Table 110. Nanyue Biopharming Corporation Information
Table 111. Nanyue Biopharming Description and Business Overview
Table 112. Nanyue Biopharming Human Immunoglobulin (pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Nanyue Biopharming Human Immunoglobulin (pH4) for Intravenous Injection Product
Table 114. Nanyue Biopharming Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Human Immunoglobulin (pH4) for Intravenous Injection Distributors List
Table 118. Human Immunoglobulin (pH4) for Intravenous Injection Customers List
Table 119. Human Immunoglobulin (pH4) for Intravenous Injection Market Trends
Table 120. Human Immunoglobulin (pH4) for Intravenous Injection Market Drivers
Table 121. Human Immunoglobulin (pH4) for Intravenous Injection Market Challenges
Table 122. Human Immunoglobulin (pH4) for Intravenous Injection Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Immunoglobulin (pH4) for Intravenous Injection
Figure 2. Global Human Immunoglobulin (pH4) for Intravenous Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Human Immunoglobulin (pH4) for Intravenous Injection Market Share by Type in 2023 & 2030
Figure 4. 1g/20ml Product Picture
Figure 5. 1.25g/25ml Product Picture
Figure 6. 2.5g/50ml Product Picture
Figure 7. 5g/100ml Product Picture
Figure 8. 10g/200ml Product Picture
Figure 9. Global Human Immunoglobulin (pH4) for Intravenous Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Human Immunoglobulin (pH4) for Intravenous Injection Market Share by Application in 2023 & 2030
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Others
Figure 14. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Human Immunoglobulin (pH4) for Intravenous Injection Market Size (2019-2030) & (US$ Million)
Figure 16. Global Human Immunoglobulin (pH4) for Intravenous Injection Sales (2019-2030) & (K Units)
Figure 17. Global Human Immunoglobulin (pH4) for Intravenous Injection Average Price (US$/Unit) & (2019-2030)
Figure 18. Human Immunoglobulin (pH4) for Intravenous Injection Report Years Considered
Figure 19. Human Immunoglobulin (pH4) for Intravenous Injection Sales Share by Manufacturers in 2023
Figure 20. Global Human Immunoglobulin (pH4) for Intravenous Injection Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Human Immunoglobulin (pH4) for Intravenous Injection Players: Market Share by Revenue in 2023
Figure 22. Human Immunoglobulin (pH4) for Intravenous Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Human Immunoglobulin (pH4) for Intravenous Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Country (2019-2030)
Figure 25. North America Human Immunoglobulin (pH4) for Intravenous Injection Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Country (2019-2030)
Figure 29. Europe Human Immunoglobulin (pH4) for Intravenous Injection Revenue Market Share by Country (2019-2030)
Figure 30. Germany Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection Revenue Market Share by Region (2019-2030)
Figure 37. China Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Country (2019-2030)
Figure 48. Latin America Human Immunoglobulin (pH4) for Intravenous Injection Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Human Immunoglobulin (pH4) for Intravenous Injection Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE Human Immunoglobulin (pH4) for Intravenous Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Human Immunoglobulin (pH4) for Intravenous Injection by Type (2019-2030)
Figure 58. Global Revenue Market Share of Human Immunoglobulin (pH4) for Intravenous Injection by Type (2019-2030)
Figure 59. Global Human Immunoglobulin (pH4) for Intravenous Injection Price (US$/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Human Immunoglobulin (pH4) for Intravenous Injection by Application (2019-2030)
Figure 61. Global Revenue Market Share of Human Immunoglobulin (pH4) for Intravenous Injection by Application (2019-2030)
Figure 62. Global Human Immunoglobulin (pH4) for Intravenous Injection Price (US$/Unit) by Application (2019-2030)
Figure 63. Human Immunoglobulin (pH4) for Intravenous Injection Value Chain
Figure 64. Human Immunoglobulin (pH4) for Intravenous Injection Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
